# OnCo record epcore-dlbcl-1 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/epcore-dlbcl-1/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "epcore-dlbcl-1", "NCT04628494" ;
  schema:name "EPCORE DLBCL-1"@en ;
  schema:description "Epcoritamab delayed progression but did not clearly extend life versus chemotherapy in relapsed lymphoma, missing its US primary endpoint in January 2026."@en ;
  schema:url <https://onco.cc/trials/epcore-dlbcl-1/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04628494> ;
  onco:status "mixed" ;
  onco:phase "3" ;
  schema:startDate "2021-01-13" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/> ;
  onco:technologies <https://onco.cc/technologies/t-cell-engager/> ;
  onco:drugs <https://onco.cc/drugs/epcoritamab/> ;
  onco:companies <https://onco.cc/companies/genmab/> ;
  onco:people <https://onco.cc/people/catherine-thieblemont/> .